These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37165775)

  • 61. Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.
    Stone MT; Weed V; Kulich RJ
    Curr Pain Headache Rep; 2016 Sep; 20(9):51. PubMed ID: 27474093
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Lipton RB; Munjal S; Buse DC; Bennett A; Fanning KM; Burstein R; Reed ML
    Headache; 2017 Jul; 57(7):1026-1040. PubMed ID: 28603893
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Primary headache and migraine in headache specialists - does personal history of doctors matter?
    Evers S; Brockmann N; Summ O; Husstedt IW; Frese A
    Cephalalgia; 2020 Jan; 40(1):96-106. PubMed ID: 31480900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment patterns of isolated benign headache in US emergency departments.
    Vinson DR
    Ann Emerg Med; 2002 Mar; 39(3):215-22. PubMed ID: 11867972
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Health care resource utilization following initiation of a triptan: a retrospective claims analysis.
    Messali A; Owens G; Bloudek L; Kori S; Cole A; Chia J
    J Manag Care Spec Pharm; 2014 Apr; 20(4):368-75. PubMed ID: 24684641
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Botulinum toxins for the prevention of migraine in adults.
    Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
    Landy SH
    Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
    Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
    Headache; 2015; 55(7):984-91. PubMed ID: 26129705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of headache on a supplemental healthcare emergency unit and on use of opioids.
    Silva AVD; Kiy LMC; Alves CA; Kirylko GC; Bello VA; Poli-Frederico RC
    Arq Neuropsiquiatr; 2021 Jul; 79(7):579-583. PubMed ID: 34287507
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain.
    Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N
    Int J Drug Policy; 2022 Jul; 105():103708. PubMed ID: 35544972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
    Chu MK; Buse DC; Bigal ME; Serrano D; Lipton RB
    Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Self-medication of regular headache: a community pharmacy-based survey in Belgium].
    Mehuys E; Paemeleire K; Van Hees T; Christiaens T; Van Bortel L; Van Tongelen I; Philippe G; Prévôt ML; Evrard B; Piette M; De Bolle L; Remon JP; Boussery K
    J Pharm Belg; 2012 Jun; (2):4-10. PubMed ID: 22978009
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of Childhood Migraine by Headache Specialist vs Non-Headache Specialists.
    Gutta R; Valentini KJ; Kaur G; Farooqi AA; Sivaswamy L
    Headache; 2019 Oct; 59(9):1537-1546. PubMed ID: 31557328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Burden of migraine in a Kuwaiti population: a door-to-door survey.
    Al-Hashel JY; Ahmed SF; Alroughani R
    J Headache Pain; 2017 Oct; 18(1):105. PubMed ID: 29030731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.
    Lipton RB; Silberstein SD
    Headache; 2015 Mar; 55 Suppl 2():103-22; quiz 123-6. PubMed ID: 25662743
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessing evidence-based medicine and opioid/barbiturate as first-line acute treatment of pediatric migraine and primary headache: A retrospective observational study of health systems data.
    Seng EK; Gelfand AA; Nicholson RA
    Cephalalgia; 2019 Jul; 39(8):1000-1009. PubMed ID: 30786733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic migraine: current concepts and ongoing treatments.
    Negro A; Rocchietti-March M; Fiorillo M; Martelletti P
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1401-20. PubMed ID: 22288302
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients.
    Danno D; Iigaya M; Imai N; Igarashi H; Takeshima T
    Sci Rep; 2019 Jul; 9(1):9900. PubMed ID: 31289281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.